Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Citi
AstraZeneca
McKinsey
Medtronic
Queensland Health
UBS
Colorcon
Baxter

Generated: May 21, 2018

DrugPatentWatch Database Preview

Trandolapril - Generic Drug Details

or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for trandolapril and what is the scope of trandolapril patent protection?

Trandolapril
is the generic ingredient in four branded drugs marketed by Abbvie, Aurobindo Pharma, Cipla, Dr Reddys Labs Ltd, Epic Pharma, Epic Pharma Llc, Invagen Pharms, Lupin, Mylan, Teva Pharms, Watson Labs, and Glenmark Generics, and is included in thirteen NDAs. Additional information is available in the individual branded drug profile pages.

There are ten drug master file entries for trandolapril. Nine suppliers are listed for this compound.
Pharmacology for trandolapril
Synonyms for trandolapril
(2S,3aR,7aS)-1-(((S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl)-L-alanyl)octahydro-1H-indole-2-carboxylic acid
(2S,3aR,7aS)-1-((S)-N-((S)-1-Carboxy-3-phenylpropyl)alanyl)hexahydro-2-indolinecarboxylic acid, 1-ethyl ester
(2S,3aR,7aS)-1-(N-((1S)-1-((Ethyloxy)carbonyl)-3-phenylpropyl)-L-alanyl)octahydro-1H-indole-2-carboxylic Acid
(2s,3ar,7as)-1-[(2s)-2-[[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]octahydro-1h-indole-2-carboxylic acid
(2S,3aR,7aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxidanylidene-4-phenyl-butan-2-yl]amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid
(2S,3aR,7aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]-1-oxopropyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid
(2S,3aR,7aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid
(2S,3aR,7aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylicacid
(2S,3aR,7aS)-1-[(2S)-2-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}propanoyl]-octahydro-1H-indole-2-carboxylic acid
1-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)octahydro-1H-indol-2-carboxylic acid
1H-Indole-2-carboxylic acid, 1-((2S)-2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)octahydro-, (2S,3aR,7aS)-
1H-Indole-2-carboxylic acid, octahydro-1-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)-, (2S-(1(R*(R*)),2-alpha,3a-alpha,7a-beta))-
1T0N3G9CRC
679T376
87679-37-6
A842336
AC1NUNSR
AK163083
AKOS015843316
AKOS015896050
AM035968
API0004465
AX8035229
BDBM50369775
BG0519
BIDD:GT0804
C24H34N2O5
CAS-87679-37-6
CCG-222228
CCRIS 6594
CHEBI:9649
CHEMBL1519
CI-907
CS-2809
CTK8E8021
D00383
D0M5OC
DB00519
DR002663
DSSTox_CID_3692
DSSTox_GSID_23692
DSSTox_RID_77151
DTXSID2023692
FT-0082544
Gopten
GTPL6453
HMS3262J10
HY-B0592
I06-1849
Indolapril
KB-81195
KS-1467
LP00924
LS-82763
Mavik
Mavik (TN)
MFCD00865776
MolPort-006-167-568
NCGC00095153-01
NCGC00182079-02
NCGC00182079-03
NCGC00261609-01
Odric
Odrik
Preran
RU 44570
RU-44570
RU44570
SC-17973
SCHEMBL16610
SR-02000000917
SR-02000000917-2
ST24050183
TC-070968
Tox21_111453
Tox21_113152
Tox21_500924
Trandolapril (JAN/INN)
Trandolapril [INN:BAN]
Trandolapril [USP:INN:BAN]
Trandolapril, >=98% (HPLC), white powder
Trandolapril, European Pharmacopoeia (EP) Reference Standard
Trandolapril, United States Pharmacopeia (USP) Reference Standard
Trandolaprilum
Trandolaprilum [Latin]
Udrik
UNII-1T0N3G9CRC
VXFJYXUZANRPDJ-WTNASJBWSA-N
ZINC1853205

US Patents and Regulatory Information for trandolapril

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Pharms TRANDOLAPRIL trandolapril TABLET;ORAL 077489-003 Dec 12, 2006 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Mylan TRANDOLAPRIL trandolapril TABLET;ORAL 078346-003 Apr 28, 2008 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Abbvie MAVIK trandolapril TABLET;ORAL 020528-003 Apr 26, 1996 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Glenmark Generics TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE trandolapril; verapamil hydrochloride TABLET, EXTENDED RELEASE;ORAL 079135-003 May 5, 2010 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Expired US Patents for trandolapril

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbvie MAVIK trandolapril TABLET;ORAL 020528-003 Apr 26, 1996 ➤ Try a Free Trial ➤ Try a Free Trial
Abbvie MAVIK trandolapril TABLET;ORAL 020528-001 Apr 26, 1996 ➤ Try a Free Trial ➤ Try a Free Trial
Abbvie MAVIK trandolapril TABLET;ORAL 020528-001 Apr 26, 1996 ➤ Try a Free Trial ➤ Try a Free Trial
Abbvie MAVIK trandolapril TABLET;ORAL 020528-002 Apr 26, 1996 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Merck
Dow
Johnson and Johnson
McKesson
Cerilliant
Chubb
QuintilesIMS
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.